IZUN PHARMACEUTICALS CORP — Form D
IZUN PHARMACEUTICALS CORP of JERUSALEM, L3, a company, filed a Form D exempt-offering notice with the SEC on 2012-06-19. $4.1M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2012-06-19
- Form: D
- Accession: 0001406071-12-000001
- Industry: Pharmaceuticals
- Exemptions: 06
- Amount sold: $4.1M
- Minimum investment: $8K
- Investors: 14
- Date of first sale: 2012-05-31
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-179972
Issuer
- Name: IZUN PHARMACEUTICALS CORP
- CIK: 0001406071
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 5 KIRYAT HAMADA STREET, JERUSALEM, L3, 91042
- Phone: 011-972-2-586-1814
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| Benjamin Z Jesselson | Director | Jerusalem, L3 |
| Yarom Z Oren | Director | Jerusalem, L3 |
| Avner Z Rotman | Director | Rehovot, L3 |
| Aron Z Saffer | Director | Beit Shemesh, L3 |
| Aron Z Saffer | Executive Officer | Beit Shemesh, L3 |
| Oscar Z Schafer | Director | New York, NY |
| William Z Levine | Director | Jerusalem, L3 |
| William Z Levine | Executive Officer | Jerusalem, L3 |
| Robert Z Citron | Executive Officer | Jerusalem, L3 |
| Hersch Z Cooper | Director | Jerusalem, L3 |
| Elliot Z Hahn | Director | N. Miami Beach, FL |
| Jeremy Z Kon | Director | London NW 11,, X0 |
Other filings by this issuer (1)
More